Continuous Glucose Monitoring and Type 1 Diabetes Mellitus Control in Child, Adolescent and Young Adult Population – Arguments for Its Use and Effects

Sensors for continuous glucose monitoring (CGM) in intercellular fluid are used as a contemporary method to achieve better control in type 1 diabetes mellitus (DM), which is best shown through lower glycated hemoglobin (HbA1c) levels.The aim of this study was to assess how many of our patients us...

Full description

Bibliographic Details
Main Authors: Karla Rubelj, Gordana Stipančić, Lavinia La Grasta Sabolić, Marija Požgaj Šepec
Format: Article
Language:English
Published: Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2021-01-01
Series:Acta Clinica Croatica
Subjects:
Online Access:https://hrcak.srce.hr/file/399089
_version_ 1797206711848665088
author Karla Rubelj
Gordana Stipančić
Lavinia La Grasta Sabolić
Marija Požgaj Šepec
author_facet Karla Rubelj
Gordana Stipančić
Lavinia La Grasta Sabolić
Marija Požgaj Šepec
author_sort Karla Rubelj
collection DOAJ
description Sensors for continuous glucose monitoring (CGM) in intercellular fluid are used as a contemporary method to achieve better control in type 1 diabetes mellitus (DM), which is best shown through lower glycated hemoglobin (HbA1c) levels.The aim of this study was to assess how many of our patients used CGM (parents were solely financing all the cost of the device) and what was the effect of CGM on the control of DM. Data were retrospectively collected from medical records of patients actively treated at the Division of Endocrinology, Diabetology, Pulmonology and Allergology, Department of Pediatrics, Sestre milosrdnice University Hospital Center. The t-test was used for independent samples to compare the mean levels of HbA1c before and after the inclusion of CGM. CGM was used by 81 (32.1%) of our patients with type 1 DM, of which 43 met the inclusion criteria. The mean HbA1c level 6 months before the introduction of CGM was 8.2%±1.9 and after 12 months of CGM use it was 7.4%±1.2, which was a statistically significant improvement (p=0.026). Furthermore, our results demonstrated that the greatest improvement in HbA1c level was recorded in the groups of young adults (18-25 years) and youngest children (<12 years). We confirmed the efficacy of CGM in achieving better control of type 1 DM by significantly improving HbA1c levels in a population of highly motivated patients.
first_indexed 2024-04-24T09:11:22Z
format Article
id doaj.art-3ee671658e3248a58c2338adc7fe4a18
institution Directory Open Access Journal
issn 0353-9466
1333-9451
language English
last_indexed 2024-04-24T09:11:22Z
publishDate 2021-01-01
publisher Sestre Milosrdnice University hospital, Institute of Clinical Medical Research
record_format Article
series Acta Clinica Croatica
spelling doaj.art-3ee671658e3248a58c2338adc7fe4a182024-04-15T17:40:20ZengSestre Milosrdnice University hospital, Institute of Clinical Medical ResearchActa Clinica Croatica0353-94661333-94512021-01-0160.4.60961510.20471/acc.2021.60.04.07Continuous Glucose Monitoring and Type 1 Diabetes Mellitus Control in Child, Adolescent and Young Adult Population – Arguments for Its Use and EffectsKarla Rubelj0Gordana Stipančić1Lavinia La Grasta Sabolić2Marija Požgaj Šepec3Department of Pediatrics, Sestre milosrdnice University Hospital Center, Zagreb, CroatiaDepartment of Pediatrics, Sestre milosrdnice University Hospital Center, Zagreb, Croatia; Department of Pediatrics, School of Dental Medicine, University of Zagreb, Zagreb, CroatiaDepartment of Pediatrics, Sestre milosrdnice University Hospital Center, Zagreb, CroatiaDepartment of Pediatrics, Sestre milosrdnice University Hospital Center, Zagreb, CroatiaSensors for continuous glucose monitoring (CGM) in intercellular fluid are used as a contemporary method to achieve better control in type 1 diabetes mellitus (DM), which is best shown through lower glycated hemoglobin (HbA1c) levels.The aim of this study was to assess how many of our patients used CGM (parents were solely financing all the cost of the device) and what was the effect of CGM on the control of DM. Data were retrospectively collected from medical records of patients actively treated at the Division of Endocrinology, Diabetology, Pulmonology and Allergology, Department of Pediatrics, Sestre milosrdnice University Hospital Center. The t-test was used for independent samples to compare the mean levels of HbA1c before and after the inclusion of CGM. CGM was used by 81 (32.1%) of our patients with type 1 DM, of which 43 met the inclusion criteria. The mean HbA1c level 6 months before the introduction of CGM was 8.2%±1.9 and after 12 months of CGM use it was 7.4%±1.2, which was a statistically significant improvement (p=0.026). Furthermore, our results demonstrated that the greatest improvement in HbA1c level was recorded in the groups of young adults (18-25 years) and youngest children (<12 years). We confirmed the efficacy of CGM in achieving better control of type 1 DM by significantly improving HbA1c levels in a population of highly motivated patients.https://hrcak.srce.hr/file/399089Type 1 diabetes mellitusContinuous glucose monitoringChildrenAdolescents
spellingShingle Karla Rubelj
Gordana Stipančić
Lavinia La Grasta Sabolić
Marija Požgaj Šepec
Continuous Glucose Monitoring and Type 1 Diabetes Mellitus Control in Child, Adolescent and Young Adult Population – Arguments for Its Use and Effects
Acta Clinica Croatica
Type 1 diabetes mellitus
Continuous glucose monitoring
Children
Adolescents
title Continuous Glucose Monitoring and Type 1 Diabetes Mellitus Control in Child, Adolescent and Young Adult Population – Arguments for Its Use and Effects
title_full Continuous Glucose Monitoring and Type 1 Diabetes Mellitus Control in Child, Adolescent and Young Adult Population – Arguments for Its Use and Effects
title_fullStr Continuous Glucose Monitoring and Type 1 Diabetes Mellitus Control in Child, Adolescent and Young Adult Population – Arguments for Its Use and Effects
title_full_unstemmed Continuous Glucose Monitoring and Type 1 Diabetes Mellitus Control in Child, Adolescent and Young Adult Population – Arguments for Its Use and Effects
title_short Continuous Glucose Monitoring and Type 1 Diabetes Mellitus Control in Child, Adolescent and Young Adult Population – Arguments for Its Use and Effects
title_sort continuous glucose monitoring and type 1 diabetes mellitus control in child adolescent and young adult population arguments for its use and effects
topic Type 1 diabetes mellitus
Continuous glucose monitoring
Children
Adolescents
url https://hrcak.srce.hr/file/399089
work_keys_str_mv AT karlarubelj continuousglucosemonitoringandtype1diabetesmellituscontrolinchildadolescentandyoungadultpopulationargumentsforitsuseandeffects
AT gordanastipancic continuousglucosemonitoringandtype1diabetesmellituscontrolinchildadolescentandyoungadultpopulationargumentsforitsuseandeffects
AT lavinialagrastasabolic continuousglucosemonitoringandtype1diabetesmellituscontrolinchildadolescentandyoungadultpopulationargumentsforitsuseandeffects
AT marijapozgajsepec continuousglucosemonitoringandtype1diabetesmellituscontrolinchildadolescentandyoungadultpopulationargumentsforitsuseandeffects